SCHEMBL7606676

SCHEMBL7606676

Cc1cc(CN)ccc1NC(=O)c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.67
CYP2C19 P33261 2/20 0.67
CYP1A2 P05177 1/20 0.67
CYP2C9 P11712 1/20 0.67
POLB P06746 2/20 0.59
HPGD P15428 1/20 0.59
ALDH1A1 P00352 1/20 0.57
NR1H4 Q96RI1 1/20 0.56
PTGDR2 Q9Y5Y4 1/20 0.55
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
LTC4S Q16873 1/20 0.54
HDAC1 Q13547 2/20 0.53
TP53 P04637 1/20 0.52
CYP3A4 P08684 1/20 0.51
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
CFD P00746 1/20 0.49
F11 P03951 1/20 0.49
TPSB2 P20231 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13129153 0.88 LTC4S (0.68) MAPTCYP2C19CYP1A2CYP2C9POLB
SCHEMBL25518944 0.83 MAPT (0.59) MAPTCYP2C19CYP1A2CYP2C9POLB
SCHEMBL28787280 0.82 LTC4S (0.54) MAPTCYP2C19CYP1A2CYP2C9ALDH1A1
SCHEMBL1548172 0.80 MAPT (1.00) MAPTCYP2C19CYP1A2CYP2C9POLB
SCHEMBL8820818 0.80 MAPT (0.71) MAPTCYP2C19CYP1A2CYP2C9POLB
SCHEMBL620069 0.79 RAB9A (0.53) MAPTCYP2C19CYP1A2POLBALDH1A1
SCHEMBL14900902 0.79 POLB (0.72) MAPTCYP2C19CYP1A2CYP2C9POLB
SCHEMBL30739671 0.78 MAPT (0.69) MAPTCYP2C19CYP1A2CYP2C9POLB
SCHEMBL30798823 0.78 MAPT (0.69) MAPTCYP2C19CYP1A2CYP2C9POLB
SCHEMBL7890737 0.78 MAPT (0.69) MAPTCYP2C19CYP1A2CYP2C9POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments MTTP, CETP, FABP1 MAPT 4022/4885CYP2C19 200/4885CYP1A2 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.